ALO:EURONEXT PARISAlstom SA Analysis
Data as of 2026-09-06 - not real-time
€16.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Alstom SA is priced at €16.50, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it gained 3.1%. With RSI at 54.6 the momentum picture is neutral, alongside a bearish MACD signal. Watch €15.54 as support and €17.06 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 27.5 sits in line with the sector average of 28.5. Sell-side targets cluster 29.9% above the current quote. Revenue is growing at 4.1% on a 1.7% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 28.8%, a beta of 0.16 and a maximum drawdown of 49.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.
Valuation screens as undervalued: a P/E of 27.5 sits in line with the sector average of 28.5. Sell-side targets cluster 29.9% above the current quote. Revenue is growing at 4.1% on a 1.7% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 28.8%, a beta of 0.16 and a maximum drawdown of 49.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.
Top Market Events
Alstom stock on Euronext Paris is trading below the prevailing analyst target consensus, with recentAlstom stock trades in the mid-teens in euros as investors weigh the French rail maker’s deleveragin
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 20.88
- MACD momentum is negative
- Maximum drawdown of 49.7%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 27.5 versus sector average of 28.5
- Trading below the 200-day average of 20.88
- Analyst targets imply +29.9% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 27.5 versus sector average of 28.5
- Analyst targets imply +29.9% versus the current price
- Price-to-book of 0.77
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin1.69%
P/E Ratio27.5
ROE3.41%
ROA1.19%
Debt/Equity32.97
P/B Ratio0.8
Op. Cash Flow€891.0M
Free Cash Flow€567.9M
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI54.6
Support€15.54
Resistance€17.06
MA 20€16.17
MA 50€16.03
MA 200€20.88
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Fair Value€15.81
Target Price€21.43
Upside/Downside29.87%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.16
Volatility28.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.